SEARCH

Search any criteria by typing into the box above or browse from the links below.
Click on drug name or to access monograph.

Inhaler $1.46, Nebule $1.46

Ipratropium Bromide

Editor: Updated Class:

ADMINISTRATION ROUTES:

Inhaled, Nebulised

ALTERNATIVE NAMES:

Atrovent, Combivent (ipratropium + salbutamol), Duolin (ipratropium + salbutamol)

ICU INDICATIONS:

  1. Bronchospasm

PRESENTATION AND ADMINISTRATION:

Inhaled:

Atrovent inhaler 20 mcg/dose

Combivent inhaler 20 mcg atrovent per dose and 100 mcg salbutamol per dose

Nebulised:

Ipratropium steri-neb 500 mcg/2 mL

Duolin 500 mcg ipratropium and salbutamol 2.5mg per 2.5 mL

DOSAGE:

Inhaled:

2 puffs QID

If ventilated, 5 puffs into circuit via metered dose inhaler adapter

Nebulised:

1 vial Ipratropium or Duolin QID

DOSAGE IN RENAL FAILURE AND RENAL REPLACEMENT THERAPY:

Dose as in normal renal function

DOSAGE IN PAEDIATRICS:

Nebulised:

0.25 - 1 mL of 250 mcg/mL solution diluted to 4 mL

In severe bronchospasm, administer every 20 minutes for 3 doses, then administer 4 - 6 hourly

CLINICAL PHARMACOLOGY:

Ipratropium bromide is an anticholinergic (parasympatholytic) agent. Anticholinergics prevent the increases in intracellular concentration of cyclic guanosine monophosphate (cyclic GMP) which are caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle.

CONTRAINDICATIONS:

  1. Hypersensitivity to ipratropium bromide
  2. Hypersensitivity to atropine or its derivatives

WARNINGS:

Immediate hypersensitivity reactions may occur after administration of ipratropium bromide, as demonstrated by rare cases of urticaria, angioedema, rash, bronchospasm, anaphylaxis and oropharyngeal oedema.

Inhaled medicines, including ipratropium bromide, may cause paradoxical bronchospasm. If this occurs, treatment with ipratropium bromide aerosol should be stopped and other treatments.

PRECAUTIONS:

General:

Ipratropium should be used with caution in patients with narrow-angle glaucoma, prostatic hypertrophy or bladder-neck obstruction.

Laboratory Tests:

No tests in addition to routine ICU tests are required.

Drug/Laboratory Test Interactions:

None noted.

IMPORTANT DRUG INTERACTIONS IN ICU:

None of note

ADVERSE REACTIONS:

Body as a Whole:

Back pain, headache

Central and Peripheral Nervous System:

Dizziness

GI System:

Dyspepsia, dry mouth, nausea

Respiratory System:

Coughing, dyspnoea, rhinitis, sinusitis

Urinary System:

Urinary tract infection